Carregant...

Quality of Life in Physical, Social, and Cognitive Domains Improves with Endovascular Therapy in the DEFUSE 3 Trial

BACKGROUND AND PURPOSE: The DEFUSE 3 randomized clinical trial demonstrated the efficacy of endovascular therapy in treating ischemic stroke 6 to 16 hours after onset, resulting in better functional outcomes than standard medical therapy alone. The objective of this secondary analysis is to analyze...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stroke
Autors principals: Polding, Laura C, Tate, William J, Mlynash, Michael, Marks, Michael P, Heit, Jeremy J, Christensen, Soren, Kemp, Stephanie, Albers, Gregory W, Lansberg, Maarten G
Format: Artigo
Idioma:Inglês
Publicat: 2021
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7987886/
https://ncbi.nlm.nih.gov/pubmed/33596675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.120.031490
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!